Filing Details
- Accession Number:
- 0000921895-19-002005
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-15 16:32:08
- Reporting Period:
- 2019-07-11
- Accepted Time:
- 2019-07-15 16:32:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1274792 | Merrimack Pharmaceuticals Inc | MACK | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376960 | Jason Aryeh | 34 Sumner Rd. Greenwich CT 06831 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-11 | 100 | $5.71 | 100 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-12 | 2,400 | $5.71 | 2,500 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-07-12 | 1,000 | $5.62 | 3,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The Reporting Person may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.